Last update 23 Jan 2025

CBPD-268

Overview

Basic Info

Drug Type
Proteolysis-targeting chimeras (PROTAC)
Synonyms
Target
EP300/CBP
Mechanism
EP300/CBP inhibitors(CREBBP/EP300 inhibitors)
Therapeutic Areas
NeoplasmsUrogenital Diseases
Active Indication
Prostatic CancerCastration-Resistant Prostatic Cancer
Inactive Indication-
Originator Organization
University of Michigan College of EngineeringUniversity of Michigan College of Engineering
Active Organization
University of MichiganUniversity of MichiganUniversity of Michigan College of EngineeringUniversity of Michigan College of Engineering
Inactive Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Structure/Sequence

Molecular FormulaC44H47F2N9O5
InChIKeyNORRDWRSNUOCBV-XCIZWWPASA-N
CAS Registry2832961-58-5

Related

100 Clinical Results associated with CBPD-268
Login to view more data
100 Translational Medicine associated with CBPD-268
Login to view more data
100 Patents (Medical) associated with CBPD-268
Login to view more data
1
Literatures (Medical) associated with CBPD-268
11 Apr 2024Journal of Medicinal ChemistryQ1 · MEDICINE
Discovery of CBPD-268 as an Exceptionally Potent and Orally Efficacious CBP/p300 PROTAC Degrader Capable of Achieving Tumor Regression
Q1 · MEDICINE
100 Deals associated with CBPD-268
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Prostatic CancerPreclinical
US
University of Michigan College of EngineeringUniversity of Michigan College of Engineering
25 Mar 2024
Castration-Resistant Prostatic CancerPreclinical
US
University of MichiganUniversity of Michigan
22 Mar 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free